Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Capital/Financing Update 2023

Oct 12, 2023

62142_rns_2023-10-12_d62a8850-5382-4c9d-9ab0-d58de5ec4ce7.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [228 x 74] intentionally omitted <==

----- Start of picture text ----- ·4·Marksans Pharma Ltd.----- End of picture text -----

12[th] October, 2023 ,

To, National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E), Mumbai - 400051

To, BSE Limited P. J. Towers Dalal Street Mumbai - 400001

Sub: Intimation of Credit Ratings of Marksans Pharma Limited by CARE Ratings Ltd

We wish to inform that CARE Ratings Ltd. has assigned following credit ratings to the Bank facilities of Mark sans Pharma Limited:".,.

==> picture [393 x 91] intentionally omitted <==

----- Start of picture text ----- Facilities/ Instruments Rating Rating Action <br>Long-term bank facilities CARE A+; Stable Rating Reaffirmed;Short-term bank facilities CAREA1+ Rating Reaffirmed----- End of picture text -----

Yours faithfully, For Marksans Pharma Limited

HARSHAVAR Digitally signed by HARSHAVARDHAN DHAN PANIGRAHI Date: 2023.10.12 PANIGRAHI 12:34:15 +05'30' Harshavardhan Panigrahi Company Secretary & Compliance Officer

www.marksanspharma.com

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • Fax: +91-224001 2011 E-mail: [email protected]